Results 181 to 190 of about 59,037 (259)

Incidence, contributing factors, and predictors of diagnostic errors in medical inpatients: A retrospective cohort study

Journal of Hospital Medicine, Volume 21, Issue 8, Page 854-863, August 2026.
Abstract Background Diagnostic error is a major patient safety concern in hospitals, yet most studies have focused on selected high‐risk subgroups, leaving the broader general internal medicine inpatient population understudied. Objectives To determine the incidence, contributing factors, resulting harm, and predictors of diagnostic error in medical ...
Caterina E. Marx, Elena Hofmann, Martin Perrig, Gurpreet Dhaliwal, Wolf Hautz, Jörg P. Isenegger, Ernst Lipp, Drahomir Aujesky, Manuel R. Blum, Tobias Tritschler   +9 more
wiley   +1 more source

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial.

JAMA Cardiol
Lu H, Kosztin A, Claggett BL, Foà A, Pabón MA, Desai AS, Jhund PS, Henderson AD, Merkely B, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Amarante F, Saarinen R, De Sanctis Y, Glasauer A, McMurray JJV, Vaduganathan M, Solomon SD.   +21 more
europepmc   +1 more source

Plasma Atrial Natriuretic Peptide Concentrations and Associated Factors in Captive Dolphins: Potential Implications for Cardiovascular Assessment. [PDF]

Animals (Basel)
Yamamoto M, Hagino K, Shirakata C, Ito T, Ueda K, Omata M, Uemura A, Tanaka R.   +7 more
europepmc   +1 more source

Improvement of Microvascular Ischemia by Atrioventricular Sequential Pacing in Non‐Obstructive Hypertrophic Cardiomyopathy

Journal of Arrhythmia, Volume 42, Issue 4, August 2026.
AV sequential pacing from the right ventricular apex at optimal AV delay reduced coronary sinus lactate during higher heart rates in symptomatic non‐obstructive hypertrophic cardiomyopathy, suggesting improved myocardial metabolic efficiency and reduced supply–demand mismatch.
Muthiah Subramanian, Radhika Manukonda, Sachin Yalagudri, Daljeet Kaur Saggu, Sridevi Chennapragda, Calambur Narasimhan   +5 more
wiley   +1 more source

Worsening Heart Failure due to AV Dissociation From Safety Mode in CRT-P: A Case Requiring Urgent Generator Replacement. [PDF]

Ann Noninvasive Electrocardiol
Osada Y, Ueda N, Nakamura T, Ishibashi K, Kusano K.   +4 more
europepmc   +1 more source

The Role of Inflammation and Immunity in Cardiovascular Disease: Molecular Mechanisms and Therapeutic Targets

MedComm, Volume 7, Issue 8, August 2026.
Inflammation in cardiovascular disease is a dynamic and context‐dependent network rather than a secondary response to injury. Mitochondrial danger signaling links metabolic stress to immune activation through TLR priming, NLRP3 inflammasome amplification, cGAS–STING signaling, and immunometabolic gating, providing a basis for more precise therapeutic ...
Jiaxiang Rong, Zhen Wang, Xiaoxiao Lin, Ziwen Lei, Qianqian Huang, Hang Liu, Fei Luan, Junbo Zou, Yajun Shi   +8 more
wiley   +1 more source

Impact of Pericardial Fat on Intracardiac Atrial Impedance and Generator Impedance. [PDF]

J Arrhythm
Hamaura S, Kimura M, Toyama Y, Nishizaki K, Kinjo T, Ishida Y, Itoh T, Sasaki S, Tomita H.   +8 more
europepmc   +1 more source

Type 2 Diabetes Mellitus: Molecular Pathogenesis and Therapeutic Interventions

MedComm, Volume 7, Issue 8, August 2026.
This graphical summary illustrates the multiorgan therapeutic landscape for Type 2 diabetes mellitus (T2D), integrating molecular pathogenesis with modern treatment strategies. It depicts how current interventions, including SGLT2 inhibitors, GLP‐1 receptor agonists, and insulin secretagogues, target key organs—kidney, pancreas, gastrointestinal tract,
Shinuan Fei, Xiyue Xiong, Lu Zhang, Jian Zhang, Lawrence W. C. Chan, Hong Jiang, Qingqing Xiong, Changtao Hu, Jie Chen, Sijun Yang   +9 more
wiley   +1 more source

Novel biomarkers distinguish heart failure with preserved vs reduced ejection fraction. [PDF]

ESC Heart Fail
Hage C, Mang A, Daubert JC, Donal E, Myhre PL, Linde C, Lund LH.   +6 more
europepmc   +1 more source

Targeting of Pentraxin 3 Alleviated Cardiac Hypertrophy in Mice Induced by Angiotensin II

Clinical and Experimental Pharmacology and Physiology, Volume 53, Issue 8, August 2026.
ABSTRACT Pentraxin 3 (PTX3) responds rapidly to inflammatory signals. This study investigated the functional involvement of PTX3 in angiotensin II (Ang II)‐mediated cardiac hypertrophy pathogenesis, with particular focus on its potential regulation through inflammatory pathways and oxidative stress mechanisms.
Qiming Tan, Xiaoxuan Gong, Tian Wu, Chen Li, Kun Liu, Daorong Hou   +5 more
wiley   +1 more source